Literature DB >> 24253699

Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) on kidney tissue from systemic lupus erythematosus (SLE) patients.

Ling Guo1, Xiangdong Yang, Qing Xia, Junhui Zhen, Xuewei Zhuang, Tao Peng.   

Abstract

The aim of this study was to evaluate the expression of TIM-3 in renal tissue from patients with systemic lupus erythematosus (SLE) and patients without SLE, and to evaluate the difference of TIM-3 expression between them. A total of 272 patients with SLE as SLE group and 62 patients without SLE as control group were enrolled in the present study. Patients with SLE accepted percutaneous renal biopsy. We examined the expression of TIM-3 in renal tissue and the serological parameters in serum from all enrolled cases. The expression of TIM-3 and serological parameters were compared between the different groups. Positive staining of TIM-3 protein was seen in 97.1 % patients with SLE (264 out of 272), but 95.2 % negative staining in the cases without SLE (59 out of 62), only 3 out of 62 patients in control group were positive staining of TIM-3. There were significant differences between two groups in almost all serological markers which reflect SLE activity. There was a nearly positive correlation between pathological manifestations and expression degree of TIM-3. High immuno-reactivity of TIM-3 was found to be significantly correlated with serological grade (p < 0.001), but there was the phenomenon in control group. The results showed that there was the expression of TIM-3 in renal tissue from the patients with SLE, but rarely expression in cases without SLE. Expression of TIM-3 was associated with the diseases' activity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24253699     DOI: 10.1007/s10238-013-0264-3

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  17 in total

Review 1.  Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus.

Authors:  Hai Feng Pan; Dong Qing Ye; Xiang Pei Li
Journal:  Nat Clin Pract Rheumatol       Date:  2008-05-13

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

3.  Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.

Authors:  Laurent Monney; Catherine A Sabatos; Jason L Gaglia; Akemi Ryu; Hanspeter Waldner; Tatyana Chernova; Stephen Manning; Edward A Greenfield; Anthony J Coyle; Raymond A Sobel; Gordon J Freeman; Vijay K Kuchroo
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

4.  [Relationship between polymorphism sites of Tim-3 and allergic rhinitis in a population of Uigurs and Hans from Xinjiang Uigur Autonomous Region of China].

Authors:  Yan Wang; Zhi-lian Liu; Jie Sun; Imam Ilham; Hai-fang Hu; Hua Zhang
Journal:  Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi       Date:  2011-09

5.  T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner.

Authors:  Yoichiro Uchida; Bibo Ke; Maria Cecilia S Freitas; Hideo Yagita; Hisaya Akiba; Ronald W Busuttil; Nader Najafian; Jerzy W Kupiec-Weglinski
Journal:  Gastroenterology       Date:  2010-07-13       Impact factor: 22.682

6.  The polymorphisms of Th1 cell surface gene Tim-3 are associated in a Korean population with rheumatoid arthritis.

Authors:  Soo-Cheon Chae; Young-Ran Park; Seung-Cheol Shim; Kyung-Sik Yoon; Hun-Taeg Chung
Journal:  Immunol Lett       Date:  2004-08-15       Impact factor: 3.685

7.  The role of T-cell immunoglobulin- and mucin-domain-containing molecule-3 polymorphisms in idiopathic thrombocytopenic purpura.

Authors:  Wei Ting Du; Hai Feng Zhao; Jian Hui Xu; Dong Sheng Gu; Feng Xue; Jing Ge; Xun Wei Dong; Zhen Ping Chen; Ze Ping Zhou; Ren Chi Yang
Journal:  Hum Immunol       Date:  2009-03-28       Impact factor: 2.850

8.  Stable form of galectin-9, a Tim-3 ligand, inhibits contact hypersensitivity and psoriatic reactions: a potent therapeutic tool for Th1- and/or Th17-mediated skin inflammation.

Authors:  Haruna Niwa; Takahiro Satoh; Yuki Matsushima; Kazuki Hosoya; Kazumi Saeki; Toshiro Niki; Mitsuomi Hirashima; Hiroo Yokozeki
Journal:  Clin Immunol       Date:  2009-05-23       Impact factor: 3.969

9.  Expression of human TIM-1 and TIM-3 on lymphocytes from systemic lupus erythematosus patients.

Authors:  Y Wang; J Meng; X Wang; S Liu; Q Shu; L Gao; Y Ju; L Zhang; W Sun; C Ma
Journal:  Scand J Immunol       Date:  2008-01       Impact factor: 3.487

10.  Tim-3 expression in cervical cancer promotes tumor metastasis.

Authors:  Yang Cao; Xiaoxi Zhou; Xiaoyuan Huang; Qinlu Li; Lili Gao; Lijun Jiang; Mei Huang; Jianfeng Zhou
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

View more
  10 in total

1.  Expression of human T cell immunoglobulin domain and mucin-3 on kidney tissue from immunoglobulin A nephropathy patients.

Authors:  Xiangdong Yang; Zhao Hu; Xiyan Xia; Junhui Zhen; Xuewei Zhuang; Tao Peng
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

Review 2.  Checkpoint Molecules in Rheumatology-or the Benefits of Being Exhausted.

Authors:  Stinne Ravn Greisen; Bent Deleuran
Journal:  Curr Rheumatol Rep       Date:  2021-03-02       Impact factor: 4.592

3.  Clinical value of the sTim‑3 level in chronic kidney disease.

Authors:  Lingli Chen; Yuan Qin; Bo Lin; Xiaomei Yu; Shaoxiong Zheng; Xiumei Zhou; Xiaobin Liu; Yigang Wang; Biao Huang; Juan Jin; Liang Wang
Journal:  Exp Ther Med       Date:  2022-07-29       Impact factor: 2.751

4.  Increase in Serum Soluble Tim-3 Level Is Related to the Progression of Diseases After Hepatitis Virus Infection.

Authors:  Lingli Chen; Xiaomei Yu; Chunyan Lv; Yaping Dai; Tao Wang; Shaoxiong Zheng; Yuan Qin; Xiumei Zhou; Yigang Wang; Hao Pei; Hongming Fang; Biao Huang
Journal:  Front Med (Lausanne)       Date:  2022-05-12

5.  Distinct role of Tim-3 in systemic lupus erythematosus and clear cell renal cell carcinoma.

Authors:  Hongying Zheng; Xingqing Guo; Qingwu Tian; Hui Li; Yuanqi Zhu
Journal:  Int J Clin Exp Med       Date:  2015-05-15

6.  Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway.

Authors:  Huimin Yang; Tingting Xie; Dengren Li; Xianhong Du; Tixiao Wang; Chunyang Li; Xiaojia Song; Leiqi Xu; Fan Yi; Xiaohong Liang; Lifen Gao; Xiangdong Yang; Chunhong Ma
Journal:  Mol Metab       Date:  2019-02-26       Impact factor: 7.422

Review 7.  The Role of Immune Checkpoint Receptors in Regulating Immune Reactivity in Lupus.

Authors:  Kun-Lin Lu; Ming-Ying Wu; Chi-Hui Wang; Chuang-Wei Wang; Shuen-Iu Hung; Wen-Hung Chung; Chun-Bing Chen
Journal:  Cells       Date:  2019-10-08       Impact factor: 6.600

8.  An Emerging Role of TIM3 Expression on T Cells in Chronic Kidney Inflammation.

Authors:  Can Lu; Huihui Chen; Chang Wang; Fei Yang; Jun Li; Hong Liu; Guochun Chen
Journal:  Front Immunol       Date:  2022-01-26       Impact factor: 7.561

9.  Abnormal expression of Tim-3 antigen on peripheral blood T cells is associated with progressive disease in osteosarcoma patients.

Authors:  Hongliang Liu; Liqiang Zhi; Ning Duan; Pengxiao Su
Journal:  FEBS Open Bio       Date:  2016-07-09       Impact factor: 2.693

10.  Association of Serum T cell Immunoglobulin Domain and Mucin-3 and Interleukin-17 with Systemic Lupus Erythematosus.

Authors:  Lairun Jin; Ran Bai; Jun Zhou; Wei Shi; Liang Xu; Jun Sheng; Hui Peng; Yuelong Jin; Hui Yuan
Journal:  Med Sci Monit Basic Res       Date:  2018-10-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.